Cargando…

Tofacitinib Promotes Functional Recovery after Spinal Cord Injury by Regulating Microglial Polarization via JAK/STAT Signaling Pathway

Background: The JAK/STAT signaling pathway is the main inflammatory signal transduction pathway, whether JAK/STAT contributes the pathology of SCI and targeting the pathway will alleviate SCI needs to be addressed. Here, we explored the therapeutic effect of pan-JAK inhibitor tofacitinib (TOF) on se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Hongdao, Wang, Chenfeng, Han, Lin, Kong, Fanqi, Liu, Zhixiao, Zhang, Bangke, Chu, Wenxiang, Wang, Haibin, Wang, Liang, Li, Qisheng, Peng, Weilin, Yang, Haisong, Han, Chaofeng, Lu, Xuhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539697/ https://www.ncbi.nlm.nih.gov/pubmed/37781508 http://dx.doi.org/10.7150/ijbs.84564

Ejemplares similares

Inhibition of IL1R1 or CASP4 attenuates spinal cord injury through ameliorating NLRP3 inflammasome-induced pyroptosis
por: Wang, Chenfeng, et al.
Publicado: (2022)

Comparative study of halo-vest reduction and skull traction reduction in the treatment of cervical fracture dislocation in patients with ankylosing spondylitis
por: Wang, Liang, et al.
Publicado: (2023)

Effect of the JAK/STAT Inhibitor Tofacitinib on Macrophage Cholesterol Metabolism
por: Adorni, Maria Pia, et al.
Publicado: (2023)

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
por: Boyle, D L, et al.
Publicado: (2015)

Drug Discovery in Spinal Cord Injury With Ankylosing Spondylitis Identified by Text Mining and Biomedical Databases
por: Wang, Chenfeng, et al.
Publicado: (2022)

The association of rod curvature with postoperative outcomes in patients undergoing posterior lumbar interbody fusion for spinal stenosis: a retrospective case–control study
por: Han, Lin, et al.
Publicado: (2023)

Correction: The association of rod curvature with postoperative outcomes in patients undergoing posterior lumbar interbody fusion for spinal stenosis: a retrospective case–control study
por: Han, Lin, et al.
Publicado: (2023)

Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis
por: Di Benedetto, Paola, et al.
Publicado: (2021)

Biomechanical Evaluation of the Cross‐link Usage and Position in the Single and Multiple Segment Posterior Lumbar Interbody Fusion
por: Han, Lin, et al.
Publicado: (2022)

Tofacitinib Ameliorates Lipopolysaccharide-Induced Acute Kidney Injury by Blocking the JAK-STAT1/STAT3 Signaling Pathway
por: Yun, Yang, et al.
Publicado: (2021)

The JAK inhibitor tofacitinib ameliorates immune-mediated liver injury in mice
por: Wang, Han, et al.
Publicado: (2019)

Biomechanical and Clinical Study of Rod Curvature in Single-Segment Posterior Lumbar Interbody Fusion
por: Han, Lin, et al.
Publicado: (2022)

A new decompression technique for upper lumbar fracture with neurologic deficit-comparison with traditional open posterior surgery
por: Zhang, Bangke, et al.
Publicado: (2019)

Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis In Vivo and Baseline Signaling Profile Associates With Treatment Response
por: Palmroth, Maaria, et al.
Publicado: (2021)

Tofacitinib reduces acute lung injury and improves survival in a rat model of sepsis by inhibiting the JAK-STAT/NF-κB pathway
por: Zhang, Xinxin, et al.
Publicado: (2023)

Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series
por: Xu, Qingqing, et al.
Publicado: (2023)

The role of the JAK2-STAT3 pathway in pro-inflammatory responses of EMF-stimulated N9 microglial cells
por: Yang, Xuesen, et al.
Publicado: (2010)

Tofacitinib protects intestinal epithelial cells against oxygen-glucose deprivation/reoxygenation injury by inhibiting the JAK/STAT3 signaling pathway
por: Yang, Jing, et al.
Publicado: (2021)

Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis
por: Cutolo, Maurizio, et al.
Publicado: (2013)

Which is the Ideal JAK Inhibitor for Alopecia Areata – Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway
por: Sardana, Kabir, et al.
Publicado: (2023)

Drug discovery in spinal cord injury-induced osteoporosis: a text mining-based study
por: Wang, Chenfeng, et al.
Publicado: (2022)

Curcumin Regulates Anti-Inflammatory Responses by JAK/STAT/SOCS Signaling Pathway in BV-2 Microglial Cells
por: Porro, Chiara, et al.
Publicado: (2019)

JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib
por: Yang, Qiao, et al.
Publicado: (2018)

Effects of Hyperlipidemia on the Pharmacokinetics of Tofacitinib, a JAK 1/3 Inhibitor, in Rats
por: Won, Jong Mun, et al.
Publicado: (2023)

The role and mechanism of JAK2/STAT3 signaling pathway regulated by m6A methyltransferase KIAA1429 in osteosarcoma
por: Luo, Jiaquan, et al.
Publicado: (2023)

Targeting polarized phenotype of microglia via IL6/JAK2/STAT3 signaling to reduce NSCLC brain metastasis
por: Jin, Yu, et al.
Publicado: (2022)

Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway
por: Coelho-Santos, Vanessa, et al.
Publicado: (2012)

The influence of the ultrasonic treatment of working fluids on electrospun amorphous solid dispersions
por: Wang, Haibin, et al.
Publicado: (2023)

Rea regulates microglial polarization and attenuates neuronal apoptosis via inhibition of the NF‐κB and MAPK signalings for spinal cord injury repair
por: Xiao, Shining, et al.
Publicado: (2020)

Regulation of the JAK/STAT signaling pathway in spinal cord injury: an updated review
por: Guo, Xinyu, et al.
Publicado: (2023)

Cancer Risk in Patients Treated with the JAK Inhibitor Tofacitinib: Systematic Review and Meta-Analysis
por: Bezzio, Cristina, et al.
Publicado: (2023)

Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis
por: Morelli, Martina, et al.
Publicado: (2018)

Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis
por: Kaine, Jeffrey, et al.
Publicado: (2020)

Crocin promotes apoptosis of human skin cancer cells by inhibiting the JAK/STAT pathway
por: Wang, Gongfeng, et al.
Publicado: (2018)

The Interaction of the IFNγ/JAK/STAT1 and JAK/STAT3 Signalling Pathways in EGFR-Mutated Lung Adenocarcinoma Cells
por: Han, Yaguang, et al.
Publicado: (2022)

Suppressive Effect of Tetrahydrocurcumin on Pseudomonas aeruginosa Lipopolysaccharide-Induced Inflammation by Suppressing JAK/STAT and Nrf2/HO-1 Pathways in Microglial Cells
por: Lin, Hui-Wen, et al.
Publicado: (2022)

The dual function of microglial polarization and its treatment targets in ischemic stroke
por: Mo, Yong, et al.
Publicado: (2022)

A JAK/STAT invasion
por: Wells, William A.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_6qkgjc545sq7349nanr0jb4pa6